Specimen Validity Testing Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Product (Reagents & Assay Kits, Calibrators & Controls, Disposables); Type (Laboratory Testing, Rapid/PoC Testing); End User (Pain Management Centers, Workplaces, Criminal Justice & Law Enforcement Agencies, Drug Rehabilitation Centers, Drug Screening Laboratories, Others) and Geography
Report Code: TIPBT00002235 No. of Pages: 150 Category: Biotechnology Status: Upcoming
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION
Specimen validity testing (SVT) is the most performed testing that is used to detect the substitution dilution or adulteration in urine. Urine contains a high concentration of parent drugs and metabolites. The main object of specimen validity testing is the use of urine specimen validity test (SVT) for drug abuse testing. The urine drug screening is known as a clinical tool that helps in enhancing the workspace safety, monitoring patient's medication and prescription medication diversion. Moreover, the testing used in drug detection abuse. Specimen validity testing is trusted by government agencies and businesses to be more accurate and scientifically sound for detecting a wide range of prescription and illicit drugs.
MARKET DYNAMICS
The global specimen validity testing market is expected to grow significantly in the coming years, due to the rising number of drug screening laboratories and increasing R&D activities in the region. Moreover, the demand to perform presumptive tests is increasing due to rise in number of drug abuse population. On the other hand, increasing government support to upsurge research activities is likely to add novel opportunities for the global specimen validity testing market over the forecast period.
MARKET SCOPE
The "Global Specimen Validity Testing Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global medical device market trend analysis. The report aims to provide an overview of specimen validity testing market with detailed market segmentation by product, type, end user and geography. The global specimen validity testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading specimen validity testing market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global specimen validity testing market is segmented on the basis of product, type and end user. Based on product, the market is segmented as reagents & assay kits, calibrators & controls and disposables. Based on type, the global specimen validity testing market is segmented into laboratory testing and rapid/PoC testing. On the basis of end user, the market is segmented into pain management centers, workplaces, criminal justice & law enforcement agencies, drug rehabilitation centers, drug screening laboratories and others.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global specimen validity testing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The specimen validity testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting specimen validity testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the specimen validity testing market in these regions.MARKET PLAYERS
The reports cover key developments in the specimen validity testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from specimen validity testing market are anticipated to lucrative growth opportunities in the future with the rising demand for specimen validity testing in the global market. Below mentioned is the list of few companies engaged in the specimen validity testing market.
The report also includes the profiles of key specimen validity testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Specimen validity testing (SVT) is the most performed testing that is used to detect the substitution dilution or adulteration in urine. Urine contains a high concentration of parent drugs and metabolites. The main object of specimen validity testing is the use of urine specimen validity test (SVT) for drug abuse testing. The urine drug screening is known as a clinical tool that helps in enhancing the workspace safety, monitoring patient's medication and prescription medication diversion. Moreover, the testing used in drug detection abuse. Specimen validity testing is trusted by government agencies and businesses to be more accurate and scientifically sound for detecting a wide range of prescription and illicit drugs.
MARKET DYNAMICS
The global specimen validity testing market is expected to grow significantly in the coming years, due to the rising number of drug screening laboratories and increasing R&D activities in the region. Moreover, the demand to perform presumptive tests is increasing due to rise in number of drug abuse population. On the other hand, increasing government support to upsurge research activities is likely to add novel opportunities for the global specimen validity testing market over the forecast period.
MARKET SCOPE
The "Global Specimen Validity Testing Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global medical device market trend analysis. The report aims to provide an overview of specimen validity testing market with detailed market segmentation by product, type, end user and geography. The global specimen validity testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading specimen validity testing market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global specimen validity testing market is segmented on the basis of product, type and end user. Based on product, the market is segmented as reagents & assay kits, calibrators & controls and disposables. Based on type, the global specimen validity testing market is segmented into laboratory testing and rapid/PoC testing. On the basis of end user, the market is segmented into pain management centers, workplaces, criminal justice & law enforcement agencies, drug rehabilitation centers, drug screening laboratories and others.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global specimen validity testing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The specimen validity testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting specimen validity testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the specimen validity testing market in these regions.MARKET PLAYERS
The reports cover key developments in the specimen validity testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from specimen validity testing market are anticipated to lucrative growth opportunities in the future with the rising demand for specimen validity testing in the global market. Below mentioned is the list of few companies engaged in the specimen validity testing market.
The report also includes the profiles of key specimen validity testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Quest Diagnostics Incorporated.
- Laboratory Corporation of America
- Clinical Reference Laboratory, Inc.
- American Bio Medica Corporation
- Thermo Fisher Scientific Inc.
- ACM Global Laboratories.
- Premier Biotech, Inc.
- GenomeWeb LLC.
- Sciteck, Inc.
- Alfa Scientific Designs, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
